EASD 2024 - Breaking Barriers: Public-Private Partnerships Revolutionising Diabetes Research @EASDiabetes
EASD 2024 - Breaking Barriers: Public-Private Partnerships Revolutionising Diabetes Research  @EASDiabetes
Uploaded November 2024 | Updated September 2026, 3 days ago
What happens when academia and pharma join forces? Discover how groundbreaking collaborations between researchers and industry leaders like Lilly and Sanofi are reshaping diabetes care. 🌍 From pre-competitive initiatives to patient-driven innovations, this discussion dives into the transformative power of partnerships. Featuring Dr Melissa Thomas, Dr Elisabeth Niemoller, and Dr Michele Solimena, hosted by Vivienne Parry.

πŸ‘‰ Explore how these alliances are accelerating therapies, enhancing research, and prioritising patient impact. Don’t miss insights into the future of diabetes care!

πŸ”— Watch now and join the conversation.

#diabetes #medicalscience #partnership #innovativemedicine #diabetescare
EASD 2024 - Breaking Barriers: Public-Private Partnerships Revolutionising Diabetes Research6th EASD Early Career Academy Webinar: Best of EASD#EASD2022  Interview with Helen Colhund  and Andrew Paterson on cardiovascular disease and T1DEASD 2023 - Andrew Frankel and Daniel van Raalte debating SGLT-2 inhibition for diabetes and CKDBest of EASD 2025 by the EASD Early Career Academy - featuring Dr. Eugenia Martin-VazquezEASD 2023 - What have cohort studies taught us about the natural history of type 2 diabetes?EASD 2024: The Sky is NOT the Limit! Ensuring Safe Travel for People Living with DiabetesEASD 2025: Recurrent Severe Hypoglycaemic Events: What to do?Best of EASD 2025 by the EASD Early Career Academy – featuring Romane LartigueEASD Live 20232nd EASD Early Career Academy Webinar:  Perfecting your grant applicationMain pillars of kidney protection in diabetes, and how they may apply in type 1 diabetes
European Association for the Study of Diabetes |

EASD 2024 - Breaking Barriers: Public-Private Partnerships Revolutionising Diabetes Research

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER